NimbleHeart, Inc.

NimbleHeart, Inc. manufactures and markets the Physiotrace Smart, a patented dry electrode-based, reusable exercise ECG monitoring system cleared by the FDA (510(k)). The device is designed for early detection and prevention of sudden cardiac events through accessible, user-friendly monitoring outside traditional hospital settings. The system features a non-adhesive harness design with dry electrodes, eliminating the skin irritation and discomfort associated with traditional wet electrode systems. The company offers remote cardiac screening and preventive cardiac risk assessment services, positioning the platform for both clinical use and personal health monitoring. The Physiotrace Smart is engineered for ease of assembly, cleaning, and repackaging, with emphasis on patient comfort during extended wear and exercise testing. NimbleHeart targets individuals at cardiac risk, post-COVID patients with cardiac symptoms, and healthcare providers seeking portable, hygienic alternatives to conventional Holter monitors and exercise stress testing equipment. The company provides thorough clinical reporting and customer support services alongside device provision.